Ascend
-63%
est. 2Y upside i
Rank
#762
Sector
Fintech, Insurtech, Financial Software
Est. Liquidity
~4Y
Data Quality
Data: MediumAscend presents a strong upside opportunity for a job seeker, with an estimated 99% expected upside over a two-year horizon.
Last updated: March 10, 2026
Ascend successfully leverages its specialized platform and $250M lending commitment to capture significant market share in insurance accounting automation. Strategic partnerships and new AI-powered features drive ARR to $100M+ by 2028, justifying a $1.25B+ valuation at 12.5x ARR, a 400% upside from the estimated current valuation.
Ascend maintains its niche in insurance accounting automation, growing steadily but facing competition from larger players. ARR reaches $40M-$50M by 2028, leading to an acquisition or IPO at an estimated $437.5M valuation, representing a 75% upside from the estimated current valuation.
Incumbents like NetSuite and Tipalti expand their insurance-specific offerings, commoditizing Ascend's core features. Growth stalls, and the company struggles to raise further equity, leading to a down round or distressed sale at an estimated $75M valuation, resulting in a 70% loss for common shareholders due to liquidation preferences.
Preference Stack Risk
highInvestors hold $39M in equity preferences, which is 15.6% of the estimated $250M current valuation, meaning common stock is significantly junior.
Dilution Risk
moderateAs a Series A stage company, Ascend will likely require additional equity funding rounds, leading to further dilution for existing shareholders.
Secondary Liquidity
noneGiven its early stage, there is currently no active secondary market for Ascend's shares.
Questions to Ask at the Interview
Strategic questions based on Ascend's data — designed to show you've done your homework.
- 1
“How does Ascend plan to differentiate its specialized insurance accounting automation platform against the broader offerings of incumbents like NetSuite and Tipalti, particularly as they potentially expand into more niche insurance functionalities?”
- 2
“Given the stated $1M revenue and the significant total funding of $39M in equity plus a $250M lending commitment, what is the company's current ARR, and what are the key growth drivers expected to scale that revenue significantly over the next 12-24 months?”
- 3
“With the Series A round in early 2022, how is the company thinking about its next equity funding round, potential valuation expectations, and the timeline for a liquidity event for employees holding common stock or options?”
Community
Valuation Sentiment
Our model estimates -63% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.